-
公开(公告)号:US20220169619A1
公开(公告)日:2022-06-02
申请号:US17675778
申请日:2022-02-18
发明人: Guobin Ren , Weijie Ji , Dongxu Yi , Jiajun Huang
IPC分类号: C07D239/62
摘要: Disclosed is crystal form M of the proline hydroxylase inhibitor daprodustat, wherein the X-ray powder diffraction thereof, expressed in 2θ angles and using Cu-Ka radiation, has characteristic peaks at 4.7±0.2°, 6.5±0.2°, and 6.8±0.2°. Disclosed are the preparation method for and the use of crystal form M. The crystal form M has good light stability, high temperature stability and high humidity stability, good solubility, and high purity.
-
公开(公告)号:US12122804B2
公开(公告)日:2024-10-22
申请号:US17426951
申请日:2019-01-31
发明人: Guobin Ren , Weijie Ji , Dongxu Yi , Jiajun Huang
CPC分类号: C07J7/009 , C07B2200/13 , C07J43/003
摘要: A crystal form X of 3α-hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1′-yl)-19-nor-5β-pregnan-20-one, a preparation method of said crystal form and an application thereof in preparing a drug for treatment of central nervous system disease.
-
公开(公告)号:US11014890B2
公开(公告)日:2021-05-25
申请号:US16402314
申请日:2019-05-03
发明人: Dongxu Yi , Guobin Ren , Jian Ma , Shuhao Wen , Peiyu Zhang , Yang Liu , Xuekun Shi , Jiajun Huang , Yanqi Zhang , Shigang Ruan , Mingjun Yang , Guangxu Sun
IPC分类号: C07D215/18
摘要: Forms B and C of (R)—N-(4-chlorophenyl)-2-(cis-4-(6-fluoroquinolin-4-yl)cyclohexyl)propanamide are stable under the conditions of light, high temperature and high humidity.
-
公开(公告)号:US20220098230A1
公开(公告)日:2022-03-31
申请号:US17426951
申请日:2019-01-31
发明人: Guobin Ren , Weijie Ji , Dongxu YI , Jiajun Huang
IPC分类号: C07J7/00
摘要: A crystal form X of 3α-hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1′-yl)-19-nor-5β-pregnan-20-one, a preparation method of said crystal form and an application thereof in preparing a drug for treatment of central nervous system disease.
-
公开(公告)号:US20220033355A1
公开(公告)日:2022-02-03
申请号:US17487106
申请日:2021-09-28
发明人: Guobin REN , Dongxu YI , Weijie JI , Jiajun HUANG
IPC分类号: C07D207/404
摘要: A crystal form A of 2-(2, 5-dioxopyrrolidin-1yl)ethyl methyl fumarate has a good light irradiation stability, high-temperature stability and high-humidity stability.
-
公开(公告)号:US20220033347A1
公开(公告)日:2022-02-03
申请号:US17487047
申请日:2021-09-28
发明人: Guobin REN , Dongxu YI , Weijie JI , Jiajun HUANG
IPC分类号: C07C233/11
摘要: A crystalline form A of 2,2-bis(4-fluorophenyl)-2-phenylacetamide is provided. The crystalline form has good light stability, high temperature stability, and high humidity stability.
-
公开(公告)号:US12122762B2
公开(公告)日:2024-10-22
申请号:US17472927
申请日:2021-09-13
发明人: Guobin Ren , Dongxu Yi , Jiajun Huang
IPC分类号: C07D401/12
CPC分类号: C07D401/12 , C07B2200/13
摘要: Provided is crystal form A of N,N′-(10,17-dioxo-3,6,21,24-tetraoxa-9,11,16, 18-tetrazohexahexane-1,26-di-yl)bis(4-(6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline-4-yl) benzene sulfonamide. The crystal form has good light stability, high-temperature stability, and high-humidity stability.
-
公开(公告)号:US20220169658A1
公开(公告)日:2022-06-02
申请号:US17675576
申请日:2022-02-18
发明人: Guobin Ren , Weijie Ji , Dongxu Yi , Jiajun Huang
IPC分类号: C07D495/04
摘要: Provided are a crystal form of a gonadotropin releasing hormone antagonist, a preparation method therefor, and use thereof. A crystal form C and a crystal form D have high purity, good illumination stability, high temperature stability, and high humidity stability, and have good solubility and low hygroscopicity; the saturation solubility of the crystal form C and the crystal form D is 101.75 μg/ml and 87.21 μg/ml, respectively; when the relative humidity is increased from 0 to 50% RH, the hygroscopy gain of the crystal form C and the crystal form D is not greater than 1.76% and 0.73%, respectively; and when the relative humidity is increased from 0 to 90% RH, the hygroscopy gain of the crystal form C and the crystal form D is not greater than 3.43% and 1.61%, respectively. Therefore, the control of a production condition is facilitated, the preparation process is simple, the quality is stable, and large-scale industrial production is easy.
-
9.
公开(公告)号:US20220143019A1
公开(公告)日:2022-05-12
申请号:US17586160
申请日:2022-01-27
发明人: Guobin Ren , Weijie Ji , Dongxu Yi , Jiajun Huang
IPC分类号: A61K31/513 , A61K31/505
摘要: Disclosed are eutectic form A of Elagolix and pyrimethamine, a preparation method therefor and a use thereof. Using Cu-Kα radiation, eutectic form A has characteristic peaks represented by a 20 degree at 8.1±0.2°, 12.2±0.2°, 13.3±0.2° and 21.1±0.2° in an X-ray powder diffraction. Eutectic form A has a high purity, a good light radiation stability, a high temperature stability, a high humidity stability and an accelerated stability, is easy to store, and has a slow moisture absorption under the condition of relatively low humidity, wherein the weight gain of eutectic form A by moisture absorption is not more than 1.08% when the relative humidity increases from 0 to 60% RH. Production conditions for eutectic form A are easy to control, same has a simple preparation process and a stable quality, and is easy to industrially produce on a large-scale.
-
公开(公告)号:US20210403450A1
公开(公告)日:2021-12-30
申请号:US17472927
申请日:2021-09-13
发明人: Guobin REN , Dongxu YI , Jiajun HUANG
IPC分类号: C07D401/12
摘要: Provided is crystal form A of N, N′-(10, 17-dioxo-3, 6, 21, 24-tetraoxa-9, 11, 16, 18-tetrazohexahexane-1, 26-di-yl)bis(4-(6, 8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline-4-yl) benzene sulfonamide. The crystal form has good light stability, high-temperature stability, and high-humidity stability.
-
-
-
-
-
-
-
-
-